TD2

TD2
TD2

As an oncology CRO (contract research organization) dedicated to precision medicine, Translational Drug Development (TD2) works with innovative biotech and pharma companies to bring cancer treatments to patients as quickly as possible.

Stories by TD2

What Makes an Oncology Clinical Trial Site Stand Out?

Access to cutting-edge medicines makes clinics more attractive to patients. By ensuring their sites are trial-friendly, clinics can offer those new drugs faster than ever, says TD2’s Stephen Gately.